Who has invested in BioCryst Pharmaceuticals?

No investors are named on the public record for BioCryst Pharmaceuticals yet.

BioCryst Pharmaceuticals Funding: $350M Raised, Growth

BioCryst Pharmaceuticals funding overview

BioCryst Pharmaceuticals is based in Durham, North Carolina. BioCryst Pharmaceuticals has raised $350M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Growth announced in November 2021. The round record for BioCryst Pharmaceuticals runs through 2021; nothing later has been disclosed.

BioCryst Pharmaceuticals at a glance

Total raised: $350M
Latest round: Growth
Latest round date: November 2021
Headquarters: Durham, North Carolina

Frequently asked about BioCryst Pharmaceuticals funding

How much has BioCryst Pharmaceuticals raised?: BioCryst Pharmaceuticals has raised $350M in total disclosed funding across the rounds on record.
Who has invested in BioCryst Pharmaceuticals?: No investors are named on the public record for BioCryst Pharmaceuticals yet.
What was the latest BioCryst Pharmaceuticals funding round?: The most recent disclosed round is a Growth, announced in November 2021.
Where is BioCryst Pharmaceuticals based?: BioCryst Pharmaceuticals is based in Durham, North Carolina.
When did BioCryst Pharmaceuticals last raise?: The last disclosed BioCryst Pharmaceuticals round closed in November 2021 at Growth.

We update the BioCryst Pharmaceuticals record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Durham and their backers are listed below.

BioCryst Pharmaceuticals Funding: $350M Raised, Growth

BioCryst Pharmaceuticals funding overview

BioCryst Pharmaceuticals at a glance

Frequently asked about BioCryst Pharmaceuticals funding

Companies related to BioCryst Pharmaceuticals (18)

Browse related funding lists (3)